Rx (Prescription Medicine)
USD $ 213.00
Luprova 11.25mg 注射液是一种用于治疗激素依赖性癌症的药物，主要用于前列腺癌和子宫内膜异位症的治疗。其活性成分为 Leuprolide Acetate，是一种合成的促性腺激素释放因子（GnRH）类似物。Luprova 首先会刺激黄体生成素（LH）和卵泡刺激素（FSH）的释放，可能导致短暂的睾酮或雌激素水平升高。但经过持续给药后，它会抑制垂体腺体分泌这些激素，从而显著降低男性的睾酮水平和女性的雌激素水平。这种激素抑制在管理受性激素驱动的疾病中至关重要。对前列腺癌，它有助于减缓或阻止癌细胞的生长。在子宫内膜异位症中，它能缩小子宫内膜异位组织的体积，并缓解相关的疼痛和出血。Luprova 11.25mg 注射液的用药剂量和给药方式必须严格遵医嘱。常见的不良反应可能包括潮热、性欲下降、勃起功能障碍、疲劳以及注射部位反应。少见但严重的不良反应也可能发生。患者应将 Luprova 11.25mg 注射液存放于室温、避光、避潮，并放在儿童不易触及的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
未库存此 exact 强度的其他品牌，因此这些是其他强度的 Leuprolide. 未经开方医生建议，请勿更改剂量。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
